ctDNA of breast cancer reverse from urine

NIAID Data Ecosystem2026-03-13 收录

乳腺癌液体活检

ctDNA检测

数据链接：

https://www.ncbi.nlm.nih.gov/bioproject/PRJNA844219 数据链接链接失效反馈

官方服务：

资源简介：

Comparison of patient mutation profile by using urinary and plasma derived ctDNA in breast cancer

创建时间：

2022-06-01

DataSheet_1_Differential Mutation Detection Capability Through Capture-Based Targeted Sequencing in Plasma Samples in Hepatocellular Carcinoma.pdf

ctDNA检测

靶点突变分析

Circulating tumor DNA (ctDNA) is a promising biomarker for accurate monitoring and less invasive assessment of tumor burden and treatment response. Here, targeted next-generation sequencing (NGS) with

NIAID Data Ecosystem40

Enumeration of CTCs in the blood of patients with breast cancer.

循环肿瘤细胞检测

乳腺癌液体活检

Enumeration of CTCs in the blood of patients with breast cancer.

NIAID Data Ecosystem30

Defining the Relationship Between Cellular and Extracellular Vesicle (EV) Content in Breast Cancer via an Integrative Multi-Omic Analysis

乳腺癌液体活检

细胞外囊泡多组学分析

Much recent work has been dedicated to exploring the utility of extracellular vesicles (EVs) as circulating cancer biomarkers. This is driven by the understanding that the molecular cargo of EVs refle

NIAID Data Ecosystem20

cfDNA bisulfite sequencing of 239 breast cancer and 278 healthy subjects

乳腺癌液体活检

cfDNA甲基化检测

Breast cancer causes the most cancer-related death in women and is the costliest cancer in the US for medical service and prescription drug expenses. Breast cancer screening is recommended by differen

NIAID Data Ecosystem40

Comparison of target enrichment platforms for circulating tumor DNA detection

液体活检

ctDNA检测

Systemic comparison of two commercially available cancer panels for their performance in ctDNA detection with ultra-deep next-generation sequencing

NIAID Data Ecosystem30